Valproic acid inhibits proliferation and induces apoptosis in acute myeloid leukemia cells expressing P-gp and MRP1
- 29 April 2004
- journal article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 18 (7), 1246-1251
- https://doi.org/10.1038/sj.leu.2403390
Abstract
The multidrug resistance (MDR) phenotype, induced by the overexpression of several ABC transporters or by antiapoptotic mechanisms, has been identified as the major cause of drug resistance in the treatment of patients with acute myeloid leukemia (AML). In this study, we have shown that valproic acid (VPA) (a histone deacetylase inhibitor) can inhibit the proliferation of both P-glycoprotein (P-gp)- and MDR-associated protein 1 (MRP1)-positive and -negative cells. VPA also induced apoptosis of P-gp-positive cells. VPA induced apoptosis in K562 cells led to decrease in Flip (FLICE/caspase-8 inhibitory protein) expression with Flip cleavage, which could not be observed in HL60 cells. In HL60/MRP cell line, which proved to be resistant to apoptosis by VPA, we observed an abnormal expression of apoptotic regulatory proteins, overexpression of Bcl-2 and absence of Bax. Also, the Bcl-2 antagonist HA14-1 rapidly restored apoptosis in this cell line. Cotreatment with cytosine arabinoside induced very strong apoptosis in both K562/DOX and HL60/DNR cell lines. VPA also induced apoptosis in AML patient cells expressing P-gp and/or MRP1. Our findings show VPA as an interesting drug that should be tested in clinical trials for overcoming the MDR phenotype in AML patients.Keywords
This publication has 22 references indexed in Scilit:
- Molecular sequelae of histone deacetylase inhibition in human malignant B cellsBlood, 2003
- Cotreatment with the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) enhances imatinib-induced apoptosis of Bcr-Abl–positive human acute leukemia cellsBlood, 2003
- Histone-deacetylase inhibitors: novel drugs for the treatment of cancerNature Reviews Drug Discovery, 2002
- Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cellsThe EMBO Journal, 2001
- Histone deacetylases and cancer: causes and therapiesNature Reviews Cancer, 2001
- Synergistic growth inhibition of prostate cancer cells by 1α,25 Dihydroxyvitamin D3 and its 19-nor-hexafluoride analogs in combination with either sodium butyrate or trichostatin AOncogene, 2001
- Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2/Bcl-XL, c-Jun, and p21CIP1, but independent of p53Oncogene, 1999
- P-glycoprotein—A mediator of multidrug resistance in tumour cellsEuropean Journal Of Cancer, 1996
- Cell biological mechanisms of multidrug resistance in tumors.Proceedings of the National Academy of Sciences, 1994
- Quantitation of resistance of leukemic cells to cytosine arabinoside from BrdUrd/DNA bivariate histogramsCytometry, 1992